Comments
Loading...
Astera Labs Stock Guidance | NASDAQ:ALAB | Benzinga
Astera Labs issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/10/2025 | ALAB | Astera Labs | Q1 | 2025 | $0.28 | $0.29 | $0.25 | $151.00M | $155.00M | $133.92M | Get Alert |
| 11/04/2024 | ALAB | Astera Labs | Q4 | 2024 | $0.25 | $0.26 | $0.18 | $126.00M | $130.00M | $108.38M | Get Alert |
| 08/06/2024 | ALAB | Astera Labs | Q3 | 2024 | $0.16 | $0.17 | $0.11 | $95.00M | $100.00M | $79.34M | Get Alert |
| 05/07/2024 | ALAB | Astera Labs | Q2 | 2024 | $0.11 | $0.11 | $0.06 | $71.78M | $73.09M | $63.83M | Get Alert |
FAQ
What is the most recent guidance for Astera Labs (ALAB)?
The most recent guidance for Astera Labs (ALAB) was reported on February 10, 2025 for Q1 2025. The company provided earnings per share guidance in the range of $0.28 to $0.29, compared to the estimated EPS of $0.25. Additionally, Astera Labs forecasted revenue between $0.15B and $0.16B for the quarter.
Browse guidance and forecast on all stocks.